Filter your results
- 2
- 2
- 4
- 4
- 1
- 1
- 1
- 1
- 4
- 4
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with intellectual disability.BMC Medical Genetics, 2011, 12 (1), pp.17. ⟨10.1186/1471-2350-12-17⟩
Journal articles
inserm-00610655v1
|
||
|
Detection of Circulating Mucorales DNA in Critically Ill Burn Patients: Preliminary Report of a Screening Strategy for Early Diagnosis and TreatmentClinical Infectious Diseases, 2016, 63 (10), pp.1312--1317. ⟨10.1093/cid/ciw563⟩
Journal articles
pasteur-01405205v1
|
||
|
Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver unitsAlimentary Pharmacology & Therapeutics (Suppl), 2017, 46 (11-12), pp.1070-1076. ⟨10.1111/apt.14367⟩
Journal articles
hal-01664733v1
|
||
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapyLiver International, 2015, 35 (7), pp.1833 - 1844. ⟨10.1111/liv.12759⟩
Journal articles
istex
pasteur-01380846v1
|